Approval summary: erlotinib maintenance therapy of advanced/metastatic non-small cell lung cancer (NSCLC).

Cohen MH, Johnson JR, Chattopadhyay S, Tang S, Justice R, Sridhara R, Pazdur R

Open source

DOI
10.1634/theoncologist.2010-0257
Published
2010
Container
The oncologist
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1634/theoncologist.2010-0257,
  title = {Approval summary: erlotinib maintenance therapy of advanced/metastatic non-small cell lung cancer (NSCLC).},
  author = {Cohen MH and Johnson JR and Chattopadhyay S and Tang S and Justice R and Sridhara R and Pazdur R},
  year = {2010},
  journal = {The oncologist},
  doi = {10.1634/theoncologist.2010-0257},
  url = {https://doi.org/10.1634/theoncologist.2010-0257}
}

RIS

TY  - JOUR
TI  - Approval summary: erlotinib maintenance therapy of advanced/metastatic non-small cell lung cancer (NSCLC).
AU  - Cohen MH
AU  - Johnson JR
AU  - Chattopadhyay S
AU  - Tang S
AU  - Justice R
AU  - Sridhara R
AU  - Pazdur R
PY  - 2010
JO  - The oncologist
DO  - 10.1634/theoncologist.2010-0257
UR  - https://doi.org/10.1634/theoncologist.2010-0257
ER  - 

APA

MH, C., JR, J., S, C., S, T., R, J., R, S., & R, P. (2010). Approval summary: erlotinib maintenance therapy of advanced/metastatic non-small cell lung cancer (NSCLC).. The oncologist. https://doi.org/10.1634/theoncologist.2010-0257

Source records